DSM-Firmenich AG (XAMS:DSFIR) FFO


XAMS:DSFIR DSM-Firmenich AG XAMS:DSFIR
56 GF Score
Price €80.50
GF Value €76.41
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG FFO?

FFO (Funds from operations) only applies to REITs.

XAMS:DSFIR
56GF Score
DSM-Firmenich AG XAMS:DSFIR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DSM-Firmenich AG (XAMS:DSFIR) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of €80.50 is trading 5.4% above its estimated GF Value™ of €76.41. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for XAMS:DSFIR:

  • FFO:
  • GF Value™: €76.41 vs. price of €80.50 (5.4% above fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the XAMS:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
56GF Score

Get the complete analysis for XAMS:DSFIR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€80.50
Price
€76.41
GF Value